Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/2003
05/07/2003EP1307556A2 Compositions and methods for the therapy and diagnosis of colon cancer
05/07/2003EP1307554A2 C3b/c4b complement receptor-like molecules and uses thereof
05/07/2003EP1307553A2 Mammalian dna binding membrane-associated protein-encoding gene and uses
05/07/2003EP1307552A2 C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF
05/07/2003EP1307551A2 Human ion channels
05/07/2003EP1307550A1 Human 7tm protein receptors and polynucleotides encoding the same
05/07/2003EP1307549A2 Methods and compositions for diagnosing and treating chromosome-18p related disorders
05/07/2003EP1307548A2 Novel lipase genes
05/07/2003EP1307546A2 Ampk-related serine/threonine kinase, designated snark
05/07/2003EP1307545A2 REGULATION OF HUMAN p78-LIKE SERINE/THREONINE KINASE
05/07/2003EP1307539A2 Gene expression profile for kshv infection and methods for treating same
05/07/2003EP1307486A2 Somatostatin analogues
05/07/2003EP1307485A1 Peptide mimetics
05/07/2003EP1307484A1 Potential growth factors from the human tumour cell line ht1080
05/07/2003EP1307481A1 Inhibitory pas domain protein (ipas) and screening methods related to angiogenesis and tumor progression
05/07/2003EP1307480A2 Mutant trichosanthin
05/07/2003EP1307473A1 Purification of hbv antigens for use in vaccines
05/07/2003EP1307459A2 Indole compounds useful for the treatment of cancer
05/07/2003EP1307237A2 Complexes containing perfluoroalkyl with polar radicals, method for the production and use thereof
05/07/2003EP1307235A2 Angiogenic and osteogenic proteins for use in enhancing bone density and formation
05/07/2003EP1307228A1 Immunologic activities of rhesus cytomegalovirus encoded il-10 and human cytomegalovirus encoded il-10
05/07/2003EP1307226A2 Vitronectin receptor antagonist pharmaceuticals
05/07/2003EP1307225A2 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of cd30 or cd30l
05/07/2003EP1307220A1 Combined interferon alfa and liposomal-encapsulated all-trans retinoic acid, including preparation and use
05/07/2003EP1307219A2 Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof
05/07/2003EP1307218A1 Obesity controlling method
05/07/2003EP1307217A2 Vip-related peptides for the treatment of skin disorders
05/07/2003EP1307216A1 Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use
05/07/2003EP1307212A2 Plant derived antioxidants
05/07/2003EP1307210A2 Method and device for concentrating and stabilising conjugated oestrogens from the urine of mares
05/07/2003EP1307189A2 Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract
05/07/2003EP1307183A2 Treatment of the insulin resistance syndrome with selective cgmp pde5 inhibitors
05/07/2003EP1272512A4 Immunokine composition and method
05/07/2003EP1223968B1 Use of urodilatin for treating chronic kidney failure with residual kidney functions
05/07/2003EP1206576A4 Novel kinases and uses thereof
05/07/2003EP1143996B1 Use of a bpi protein for the preparation of a medicament for treating chronic cardiac disease
05/07/2003EP1137433B1 Pharmaceutical compositions containing protein-disulfide isomerases
05/07/2003EP1135154B1 Improvement of folliculogenesis
05/07/2003EP1131326B1 Phospholipid derivatives of non-steroidal anti-inflammatory drugs
05/07/2003EP1095036B1 Cinnamic acid derivatives as cell adhesion molecules
05/07/2003EP1061963B1 Protease inhibitors in absorbent articles
05/07/2003EP1032414B1 Combination of hypertensin converting enzyme inhibitor with a diuretic for treating microcirculation disorders
05/07/2003EP0957943B1 Matrix-free osteogenic devices, implants and methods of use thereof
05/07/2003EP0889880B1 Eprosartan dihydrate and a process for its production and formulation
05/07/2003EP0877798B1 Immortal human prostate epithelial cell lines and clones and their applications in the research and therapy of prostate cancer
05/07/2003EP0874621B1 [3'-DESOXY-3-OXO-MeBmT]1-[Val]2-CICLOSPORIN-CONTAINING EMULSION PHARMACEUTICAL COMPOSITIONS
05/07/2003EP0858464B1 Thrombin inhibitors
05/07/2003EP0854712B1 Use of creatine analogues for the treatment of disorders of glucose metabolism
05/07/2003EP0853633B1 Human monoclonal antibody against hepatitis b virus surface antigen (hbvsag)
05/07/2003EP0831893B1 Regulation of neutrophil elastase synthesis and release
05/07/2003EP0808174B1 Medicament in particle form
05/07/2003EP0773788B1 Improved compositions and methods for chemodenervation using neurotoxins
05/07/2003EP0762889B1 Heparin-binding protein for the treatment of sepsis
05/07/2003EP0749440B1 Method of isolating and purifying a biomacromolecule
05/07/2003EP0742720B1 Co-administration of interleukin-3 mutant polypeptides with csf's for multi-lineage hematopoietic cell production
05/07/2003EP0722737B1 Use of HGF for the preparation of a medicament against CNS disorders
05/07/2003EP0683234B1 Antibody against beta-amyloid or their derivative and use thereof
05/07/2003EP0674526B1 Vaccination with peptide of mhc class ii molecules for treatment of autoimmune disease
05/07/2003EP0672138B1 Chimeric procoagulant proteins
05/07/2003EP0669982B1 Materials comprising and methods of preparation and use for ribosome-inactivating proteins
05/07/2003EP0627940B1 Use of immunoconjugates for the diagnosis and/or therapy of vascularized tumors
05/07/2003CN1416472A High expression and prodn. of high-specific activity recombinant s-adenosyl homocysteinase (SAHH)and improved assays for s-adenosylmethionine (SAM)
05/07/2003CN1416461A Bacillus subtilis Var. chungkookjang producing high molecular weight poly-gumma-glutamic acid
05/07/2003CN1416411A Substance for use in dietary supplementation or for prepn. of medicament for treating non-insulin dependent diabetes mellitus, Hypertension and/or metabolic syndrome
05/07/2003CN1416354A Vascular endothelial growth factor 2
05/07/2003CN1416351A HIV immune adjuvant therapy
05/07/2003CN1416350A Novel method for down-regulation of amyloid
05/07/2003CN1416348A Modified factor VIII
05/07/2003CN1416347A Agent for treating hepatitis C
05/07/2003CN1416340A Compsns for delivery of contisol antagonist
05/07/2003CN1416322A Diabetic nutritionals
05/07/2003CN1415379A Versatile nutriment of diet therapy and beauty treatment for preventing and curing over weight or rundown condition controlled automatically and its preparation method
05/07/2003CN1415378A Injection of freeze-dried powder of growth hormone release inhibiting hormone and its preparation method
05/07/2003CN1415209A Method for preparing the bactericide and the cleansing facial milk]
05/07/2003CN1107521C Method for reducing viscosity of pathological mucoid airway contents in respiratoy tract
05/07/2003CN1107495C Desquamation compsns.
05/06/2003US6559298 Polypeptides that bind interleukin-18 (IL-18)
05/06/2003US6559289 Use of growth hormone or analogues thereof for the treatment of mammals with familial hypercholesterolemia
05/06/2003US6559288 Ninjurin
05/06/2003US6559287 Artificial glycoprotein for use in the treatment of immunological, arthritic, asthmatic, psoriasis, chronic obstructive pulmonary disorders, inflammatory bowel, osteoarthritic and viral disorders
05/06/2003US6559285 Antibody for use in the treatment of cancer
05/06/2003US6559282 Induction of antibodies against leutenizing hormone releasing hormone in mammals; obtain mammal, administer modulator, monitor immune response, evaluate for prevention of infections
05/06/2003US6559281 Non-naturally occurring synthetic lytic peptides
05/06/2003US6559280 Controlling protein levels in eucaryotic organisms
05/06/2003US6559279 Process for preparing peptide derivatized oligomeric compounds
05/06/2003US6559176 A method for regulating the activity of an autoinducer-2 receptor comprising contacting an autoinducer-2 receptor with an AI-2 agonist or antagonist compound.
05/06/2003US6559141 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
05/06/2003US6559130 Destruction of the epithelium of an exocrine gland in the prophylactic and therapeutic treatment of cancer
05/06/2003US6559129 Cationic liposomal delivery system and therapeutic use thereof
05/06/2003US6559128 Peptide blocks the site of binding between a G protein and a G protein coupled receptor in a cell
05/06/2003US6559127 Compounds which inhibit leukocyte adhesion mediated by VLA-4
05/06/2003US6559126 Peptides blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof
05/06/2003US6559124 Use of prosaposin and peptides obtained therefrom for treatment of neural degeneration
05/06/2003US6559123 Compositions to inhibit the growth of epithelial cells or heal a wound or treat a burn consisting of the chromatographically recovered polypeptide
05/06/2003US6559122 Formulated composition
05/06/2003US6559120 Recombinant allergen, fragments thereof, corresponding recombinant DNA molecules, vectors and hosts containing the DNA molecules, diagnostic and therapeutic uses of said allergens and fragments
05/06/2003US6559119 Biomedical device intended for implantation into an animal's body and having a supplemented tissue sealant composition applied to at least a portion of at least one surface thereof
05/06/2003US6558954 Phenotypic conversion of cells mediated by external guide sequences
05/06/2003US6558952 Expansion of preferential pancreatic cells; generate nutrient broth, inoculate with pancreatic cells and gastrin receptor ligand, monitor propagation of pancreatic cells
05/06/2003US6558950 Nucleotide sequences coding polypeptide for use in the treatment of programed cell death defects
1 ... 1852 1853 1854 1855 1856 1857 1858 1859 1860 1861 1862 1863 1864 1865 1866 1867 1868 1869 1870 1871 1872 ... 3163